ATLANTA, GA -- (MARKET WIRE) -- April 24, 2007 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced its participation in the upcoming 2007 Morgan Stanley Global Healthcare Conference on Wednesday, May 2, 2007, at 3:45 p.m. EDT at The Ritz-Carlton in Key Biscayne, Florida.
